Purchase Order 36C24226P0711

<p>The Department of Veterans Affairs, Veterans Integrated Service Network 2, issued a purchase order to Covermymeds Pharmacy LLC on June 4, 2026, for emergency supply of Pomalyst 4mg capsules for Brooklyn VAMC, with a ceiling value of $16,421.95. Performance occurs in Memphis, Tennessee, with a completion date of July 6, 2026. The order is firm fixed price with no small business set-aside applied.</p>

The Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a purchase order to CoverMyMeds Pharmacy LLC for the supply of Pomalyst 4mg capsules. This firm fixed-price contract, valued at $16,421.95, was awarded on March 26, 2026, with an ultimate completion date of June 26, 2026. The contract involves no set-aside designation and will be performed in Memphis, Tennessee. Pomalyst (pomalidomide) is a prescription medication used in the treatment of certain blood cancers,...

Covermymeds Pharmacy LLC was awarded a firm fixed-price purchase order valued at $872,325.86 by the Veterans Integrated Service Network 8 (VISN 8), a civilian agency within the Department of Veterans Affairs. The contract, awarded on January 16, 2026, with an ultimate completion date of April 17, 2026, covers pharmacy services to be performed in Memphis, Tennessee. No set-aside designation was applied to this award. VISN 8 serves veterans across a multi-state region and coordinates healthcare...

<p>Veterans Integrated Service Network 5 issued a BPA call to Bristol-Myers Squibb Company on May 21, 2026, for Pomalidomide (Pomalyst) 4mg capsules, with a ceiling value of $16,421.95 and an ultimate completion date of May 26, 2026. The call is placed under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract. Performance occurs in Memphis, Tennessee. The order is firm fixed price with no set-aside designation.</p>

<p>Veterans Integrated Service Network 5 issued a BPA call to Bristol-Myers Squibb Company on May 21, 2026, for POMALYST 4 MG with a ceiling value of $16,421.95. The call is issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract with the Department of Veterans Affairs. Performance is located in Memphis, Tennessee. The order is firm fixed price with an ultimate completion date of May 26, 2026.</p>

<p>The Department of Veterans Affairs, Veterans Integrated Service Network 5, issued a BPA call to Bristol-Myers Squibb Company on May 29, 2026, for POMALYST 2 MG, 3 MG, and 4 MG with a ceiling value of $149,435.80. The call was issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract. Performance occurs in Memphis, Tennessee, with an ultimate completion date of June 4, 2026. Pricing is firm fixed price with no set-aside designation.</p>

The Department of Veterans Affairs, Veterans Integrated Service Network 5, issued a BPA call to Bristol-Myers Squibb Company on May 27, 2026, for POMALYST 3 mg with a ceiling value of $10,887.57. The call was issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract, a comprehensive IDIQ vehicle covering drugs and pharmaceuticals across oncology, immunology, infectious diseases, and cardiology, with a master ceiling of $12.278 billion through April 30, 2029....

Veterans Integrated Service Network 22 awarded a purchase order to Pharmacy Buying Association, Inc. (doing business as PBA Health), a small business, for $23,378.52 on June 10, 2026, for pharmaceutical supplies. The order is a total small business set-aside with a firm fixed price and ultimate completion date of June 20, 2026. Place of performance is Kansas City, Missouri. The underlying solicitation, posted April 20, 2026, sought Memantine HCl 10mg tablets (NDC 0832-1113-60) for delivery to...

Bristol-Myers Squibb Company, a global biopharmaceutical manufacturer, received a delivery order valued at $16,421.95 for Pomalidomide (Pomalyst) 4mg capsules from Veterans Integrated Service Network 5 (VISN 5), a civilian component of the Department of Veterans Affairs. This firm fixed-price contract, awarded on February 3, 2026, with an ultimate completion date of February 6, 2026, carries no set-aside designation. The order will be fulfilled from the company's Lawrenceville, New Jersey...

The Defense Logistics Agency issued a $29,195.26 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Pomalyst 4 mg capsules (21-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with...